참고문헌
- Antje, M., Juan Carlos, R.L., Lingqiao, W., Jack, G. and Martin, K. (2006). Models of pulmonary fibrosis. J. Ddmod., 3, 243-249.
- Bethany, B.M. and Cory, M.H. (2008). Murine models of pulmonaryfibrosis. Am J Physiol. Lung Cell Mol Physiol., 294, 152-160. https://doi.org/10.1152/ajplung.00313.2007
- Bonniaud, P., Kolb, M., Galt, T., Robertson, J., Robbins, C.,Stampfli, M., Lavery, C., Margetts, P.J., Roberts, A.B. and Gauldie, J. (2004). Smad3 null mice develop airspace enlargement and are resistant to TGF-beta-mediated pulmonary fibrosis. J. Immunol., 173, 2099-2108. https://doi.org/10.4049/jimmunol.173.3.2099
- Briggs, A.D., Chandler, D.B., Jackson, R.M. and Fulmer, J.D.(1985). The effect of endotoxin on bleomycin-induced lung fibrosis in the rat. Toxicol Lett., 27, 91-96. https://doi.org/10.1016/0378-4274(85)90124-9
- Brown, R.F., Drawbaugh, R.B. and Marrs, T.C. (1988). An investigation of possible models for the production of progressive pulmonary fibrosis in the rat. The effects of repeated intratracheal instillation of bleomycin. Toxicol., 51, 101-110. https://doi.org/10.1016/0300-483X(88)90084-4
- Hemmati, A.A., Nazari, Z., Motlagh, M.E. and Goldasteh, S. (2002). The role of sodium cromolyn in treatment of paraquatinduced pulmonary fibrosis in rat. Pharmacol. Res., 46, 229-234. https://doi.org/10.1016/S1043-6618(02)00122-6
- Higashiyama, H., Yoshimoto, D., Kaise, T., Matsubara, S., Fujiwara, M., Kikkawa, H., Asano, S. and Kinoshita, M. (2007).Inhibition of activin receptor-like kinase 5 attenuates Bleomy-cin-induced pulmonary fibrosis. Exp Mol Pathol., 83, 39-46. https://doi.org/10.1016/j.yexmp.2006.12.003
- Jack, G., Martin, K., Kjetil, A., Gail, M., Philippe, B. and David, W. (2006). Smad3 signaling involved in pulmonary fibrosis and emphysema. Proc Am Thorac. Soc., 3, 696-702. https://doi.org/10.1513/pats.200605-125SF
- John, S.L., et al. (1990). BLEOMYCIN: A pharmacologic tool inthe study of the pathogenesis of interstitial pulmonary fibrosis. Pharmac. Ther., 47, 347-358.
- Manoury, B., Nenan, S., Guenon, I., Lagente, V. and Boichot, E.(2007) Influence of early neutrophil depletion on MMPs/TIMP-1 balance in bleomycin-induced lung fibrosis. Int Immunopharmacol., 7, 900-911. https://doi.org/10.1016/j.intimp.2007.02.009
- Moeller, A., Ask, K., Warburton, D., Gauldie, J. and Kolb, M.(2008). The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int J. Biochem Cell Biol., 40, 362-382. https://doi.org/10.1016/j.biocel.2007.08.011
- Oku, H., Shimizu, T., Kawabata, T., Nagira, M., Hikita, I.,Ueyama, A., Matsushima, S., Torii, M. and Arimura, A. (2008).Antifibrotic action of pirfenidone and prednisolone: Differenteffects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis. Eur J. Pharmacol.,590, 400-408. https://doi.org/10.1016/j.ejphar.2008.06.046
- Ou, X.-M., Li, W.-C., Liu, D.-S., Li, Y.-P., Wen, F.-Q., Feng, Y.-L.,Zhang, S.-F., Huang, X.-Y., Wang, T., Wang, K., Wang, X. and Chen, L. (2009). VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice. Int. Immunopharmacol.,9, 70-79. https://doi.org/10.1016/j.intimp.2008.10.002
- Ouchi, H., Fujita, M., Ikegame, S., Ye, Q., Inoshima, I., Harada, E., Kuwano, K. and Nakanishi, Y. (2008). The role of collagenases in experimental pulmonary fibrosis. Pulm Pharmacol. Ther., 21, 401-408. https://doi.org/10.1016/j.pupt.2007.10.006
- Saito, F., Tasaka, S., Inoue, K., Miyamoto, K., Nakano, Y., Ogawa,Y., Yamada, W., Shiraishi, Y., Hasegawa, N., Fujishima, S., Takano, H. and Ishizaka, A. (2008). Role of interleukin-6 in bleomycin-induced lung inflammatory changes in mice. Am. J.Respir. Cell. Mol. Biol., 38, 566-571. https://doi.org/10.1165/rcmb.2007-0299OC
- Steven, E.M., Robin, J.M., Geoffrey, J.L. and Darryl, A.K. (2004). Evaluation of experimental models of idiopathic pulmonary fibrosis. J. Ddmod., 1, 329-336.
- Thomas, A.W. (2007). Common and unique mechanisms regulatefibrosis in various fibroproliferative diseases. J. Clin. Invest.,117, 524-529. https://doi.org/10.1172/JCI31487
- Thomas, W.H., Joan, E.G., Karen, M.R., Andrew, C.J., Carroll,E.C. and Jerold, A.L. (1981). Bleomycin-induced pulmonaryfibrosis: correlation of biochemical, physiological, and histological changes. Toxicol. Appl. Pharmacol., 60, 360-367. https://doi.org/10.1016/0041-008X(91)90239-B
- Tom, W.-M. and Montgomery, M.R. (1980). Biochemical and morphological assessments of bleomycin pulmonary toxicity inrats. Toxicol. Appl. Pharmacol., 53, 64-74. https://doi.org/10.1016/0041-008X(80)90382-8
- Zhou, X.-M., Zhang, G.-C., Li, J.-X. and Hou, J. (2007). Inhibitory effects of Hu-qi-yin on the bleomycin-induced pulmonary fibrosis in rats. J. Ethnopharmacol., 111, 255-264. https://doi.org/10.1016/j.jep.2006.11.029
피인용 문헌
- Inhalation of Carbon Black Nanoparticles Aggravates Pulmonary Inflammation in Mice vol.30, pp.2, 2014, https://doi.org/10.5487/TR.2014.30.2.083
- Self-assembled Micelle Interfering RNA for Effective and Safe Targeting of Dysregulated Genes in Pulmonary Fibrosis vol.291, pp.12, 2016, https://doi.org/10.1074/jbc.M115.693671
- AQX-1125, small molecule SHIP1 activator inhibits bleomycin-induced pulmonary fibrosis vol.174, pp.18, 2017, https://doi.org/10.1111/bph.13934
- Protective Effects of Nintedanib against Polyhexamethylene Guanidine Phosphate-Induced Lung Fibrosis in Mice vol.23, pp.8, 2018, https://doi.org/10.3390/molecules23081974
- Low-dose cadmium exposure exacerbates polyhexamethylene guanidine-induced lung fibrosis in mice vol.81, pp.11, 2018, https://doi.org/10.1080/15287394.2018.1451177